NCAM1 and non-small cell lung carcinoma: Some possible explanations for the observed increase in NSCLC NOS cases during the pandemic period include the small size of biopsy samples (less than 1 mm), which often restricts immunohistochemistry panels to four or five markers (TTF1, CK7, p40, CK AE1/AE3, and CD56).